HUP0202520A2 - Szubsztituált benzil-tiazolidin-2,4-dion-származékok és az azokat tartalmazó gyógyszerkészítmények - Google Patents

Szubsztituált benzil-tiazolidin-2,4-dion-származékok és az azokat tartalmazó gyógyszerkészítmények

Info

Publication number
HUP0202520A2
HUP0202520A2 HU0202520A HUP0202520A HUP0202520A2 HU P0202520 A2 HUP0202520 A2 HU P0202520A2 HU 0202520 A HU0202520 A HU 0202520A HU P0202520 A HUP0202520 A HU P0202520A HU P0202520 A2 HUP0202520 A2 HU P0202520A2
Authority
HU
Hungary
Prior art keywords
group
optionally substituted
dione derivatives
pharmaceutical compositions
compositions containing
Prior art date
Application number
HU0202520A
Other languages
English (en)
Inventor
Hiroyuki Miyachi
Koji Murakami
Masahiro Nomura
Takahiro Tanase
Masaki Tsunoda
Original Assignee
Kyorin Pharmaceutical Co., Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kyorin Pharmaceutical Co., Ltd. filed Critical Kyorin Pharmaceutical Co., Ltd.
Publication of HUP0202520A2 publication Critical patent/HUP0202520A2/hu
Publication of HUP0202520A3 publication Critical patent/HUP0202520A3/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/34—Oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

Abstract

A találmány tárgyát új (1) általános képletű szubsztituált benzil-tiazolidin-2,4-dion-származékok - a képletben A jelentése -CH2CONH-, -NHCONH-, -CH2CH2CO- vagy -NHCOCH2-, és B jelentése 1-4 szénatomosrövid szénláncú alkilcsoport, 1-3 szénatomos rövid szénláncúalkoxicsoport, halogénatom, trifluormetilcsoport,trifluormetoxicsoport, adott esetben szubsztituált fenilcsoport, adottesetben szubsztituált fenoxicsoport vagy adott esetben szubsztituáltbenziloxicsoport és gyógyászatilag elfogadható sóik és hidrátjaik képezik, amelyekligandumként a humán peroxiszóma proliferátoraktivált receptorhoz(PPAR) kötődve aktiválják azt, és vércukor-csökkentő hatással éslipidcsökkentő hatással rendelkeznek. Ó
HU0202520A 1999-08-23 2000-08-18 Substituted benzylthiazolidine-2,4-dione derivatives and pharmaceutical compositions containing them HUP0202520A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP23552799 1999-08-23
JP2000242706 2000-08-10

Publications (2)

Publication Number Publication Date
HUP0202520A2 true HUP0202520A2 (hu) 2002-11-28
HUP0202520A3 HUP0202520A3 (en) 2004-11-29

Family

ID=26532180

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0202520A HUP0202520A3 (en) 1999-08-23 2000-08-18 Substituted benzylthiazolidine-2,4-dione derivatives and pharmaceutical compositions containing them

Country Status (10)

Country Link
US (1) US6730687B1 (hu)
EP (1) EP1213287B1 (hu)
KR (1) KR100738245B1 (hu)
CN (1) CN1155586C (hu)
AT (1) ATE296294T1 (hu)
AU (1) AU778720B2 (hu)
CA (1) CA2382574A1 (hu)
DE (1) DE60020381T2 (hu)
HU (1) HUP0202520A3 (hu)
WO (1) WO2001014349A1 (hu)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7407978B2 (en) * 1999-04-06 2008-08-05 Theracos, Inc. Heterocyclic analogs of diphenylethylene compounds
TWI262185B (en) * 1999-10-01 2006-09-21 Eisai Co Ltd Carboxylic acid derivatives having anti-hyperglycemia and anti-hyperlipemia action, and pharmaceutical composition containing the derivatives
WO2002046161A1 (fr) * 2000-12-05 2002-06-13 Kyorin Pharmaceutical Co., Ltd. Derives de l'acide carboxylique substitues
EP1911462A3 (en) 2001-01-26 2011-11-30 Schering Corporation Compositions comprising a sterol absorption inhibitor
US6908939B2 (en) 2001-12-21 2005-06-21 Galderma Research & Development S.N.C. Biaromatic ligand activators of PPARγ receptors
FR2833949B1 (fr) * 2001-12-21 2005-08-05 Galderma Res & Dev NOUVEAUX LIGANDS ACTIVATEURS DES RECEPTEURS PPARy, LEUR PROCEDE DE PREPARATION ET LEUR UTILISATION EN MEDECINE HUMAINE AINSI QU'EN COSMETIQUE
FR2836683B1 (fr) * 2002-03-01 2006-06-23 Galderma Res & Dev NOUVEAUX LIGANDS ACTIVATEURS DES RECEPTEURS PPARy, LEUR PROCEDE DE PREPARATION ET LEUR UTILISATION EN MEDECINE HUMAINE AINSI QU'EN COSMETIQUE
US7521465B2 (en) * 2003-01-17 2009-04-21 Bexel Pharmaceuticals, Inc. Diphenyl ether derivatives
US7781464B2 (en) * 2003-01-17 2010-08-24 Bexel Pharmaceuticals, Inc. Heterocyclic diphenyl ethers
US6794401B2 (en) * 2003-01-17 2004-09-21 Bexel Pharmaceuticals, Inc. Amino acid phenoxy ethers
US7087576B2 (en) 2003-10-07 2006-08-08 Bexel Pharmaceuticals, Inc. Dipeptide phenyl ethers
WO2005058813A2 (en) * 2003-12-17 2005-06-30 Ranbaxy Laboratories Limited Thiodiazolidinedione, oxazolidinedione and diazolidinedione derivatives and their use as antidiabetic agents
TW200827343A (en) * 2006-09-11 2008-07-01 Fuji Yakuhin Co Ltd Novel phenylacetic acid derivative
UY31952A (es) * 2008-07-02 2010-01-29 Astrazeneca Ab 5-metilideno-1,3-tiazolidina-2,4-dionas sustituidas como inhibidores de quinasa pim
US20130156720A1 (en) 2010-08-27 2013-06-20 Ironwood Pharmaceuticals, Inc. Compositions and methods for treating or preventing metabolic syndrome and related diseases and disorders
CN116217511B (zh) * 2023-03-22 2024-04-19 沈阳药科大学 一种双靶点化合物及其制备方法和在制备sEH抑制剂与PPARs激动剂中的应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5061717A (en) 1988-03-08 1991-10-29 Pfizer Inc. Thiazolidinedione hypoglycemic agents
US5223522A (en) * 1988-03-08 1993-06-29 Pfizer Inc. Thiazolidinedione hypoglycemic agents
JP3144624B2 (ja) * 1995-06-02 2001-03-12 杏林製薬株式会社 Ｎ−ベンジルジオキソチアゾリジルベンズアミド誘導体及びその製造法
JP3929512B2 (ja) 1995-06-02 2007-06-13 杏林製薬株式会社 Ｎ−置換ジオキソチアゾリジルベンズアミド誘導体及びその製造法
JP3906935B2 (ja) 1995-12-18 2007-04-18 杏林製薬株式会社 Ｎ−置換ジオキソチアゾリジルベンズアミド誘導体及びその製造法
AU2231397A (en) * 1996-03-08 1997-09-22 Torii Pharmaceutical Co., Ltd. Thiazolidine-2,4-dione derivatives
IL120443A (en) 1996-03-18 2000-07-16 Sankyo Co Use of an insulin sensitizer for the manufacture of a medicament for the treatment or prophylaxis of pancreatitis
JPH09301963A (ja) 1996-05-17 1997-11-25 Kyorin Pharmaceut Co Ltd Ｎ−ベンジルジオキソチアゾリジルベンズアミド誘導体及びその製造法
JP3982645B2 (ja) 1996-09-06 2007-09-26 杏林製薬株式会社 Ｎ−置換ジオキソチアゾリジルベンズアミド誘導体の製造中間体
GB0127805D0 (en) 2001-11-20 2002-01-09 Smithkline Beecham Plc Pharmaceutical composition

Also Published As

Publication number Publication date
HUP0202520A3 (en) 2004-11-29
ATE296294T1 (de) 2005-06-15
DE60020381T2 (de) 2006-01-26
EP1213287A1 (en) 2002-06-12
CA2382574A1 (en) 2001-03-01
KR20020040774A (ko) 2002-05-30
KR100738245B1 (ko) 2007-07-12
CN1155586C (zh) 2004-06-30
US6730687B1 (en) 2004-05-04
AU6594500A (en) 2001-03-19
DE60020381D1 (de) 2005-06-30
EP1213287A4 (en) 2002-09-18
EP1213287B1 (en) 2005-05-25
WO2001014349A1 (fr) 2001-03-01
AU778720B2 (en) 2004-12-16
CN1382129A (zh) 2002-11-27

Similar Documents

Publication Publication Date Title
HUP0202520A2 (hu) Szubsztituált benzil-tiazolidin-2,4-dion-származékok és az azokat tartalmazó gyógyszerkészítmények
CY1108586T1 (el) Υποκαταστημενα παραγωγα φαινυλοπροπιονικου οξεος
DK1184366T3 (da) Substituerede phenylpropionsyrederivater som agonister for human perioxisomproliferatoraktiveret receptor alpha(PPAR)
PT1213296E (pt) Derivados de glucopiranosiloxipirazole composicoes medicas que os contem e intermediarios na sua producao
TR200001816T2 (tr) Hipolipidemik benzotiyazepin bileşikleri
MA29261B1 (fr) Derives de (1,5-diphenyl-1h-pyrazol-3-yl)oxadiazole, leur preparation et leur application en therapeutique
HUP0301069A2 (hu) Új biaril-karboxamidok, eljárás az előállításukra, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk
HUP0402236A2 (hu) Heterociklusos vegyületek, az ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk
WO2004026863A8 (en) Novel oxazole and thiazole compounds as transforming growth factor (tgf) inhibitors
DE60033964D1 (de) Phenoxypropanolamin-derivate, ihre herstellung und therapeutische verwendung
MA31742B1 (fr) Derives de l'indol-2-one disubstitues en 3, leur preparation et leur application en therapeutique
MEP11508A (en) Piperazinylacylpiperidine derivatives, their preparation and therapeutic use thereof
HUP0202701A2 (hu) Szubsztituált benziltiazolidin-2,4-dion-származékok és ezeket tartalmazó gyógyszerkészítmények
HUP0202893A2 (hu) Szubsztituált benziltiazolidin-2,4-dion-származékok és ezeket tartalmazó gyógyászati készítmények
PT982305E (pt) Novos derivados do indano-1-ol proceso para a sua preparacao e as composicoes farmaceuticas que os contem
MX9301985A (es) Derivados de perhidroisoindol y procedimiento para su preparacion.
HUP0203222A2 (hu) Szubsztituált benziltiazolidin-2,4-dion-származékok és ezeket tartalmazó gyógyszerkészítmények
HUP0301561A2 (hu) Triazintrion-szulfoxidok alkalmazása kokcidiózis elleni készítmények elżállítására
FR2703679B1 (fr) Nouveaux derives de perhydroisoindole, leur preparation et les compositions pharmaceutiques qui les contiennent.
MXPA04000620A (es) Uso de derivados de tiazol para elaboracion de medicamento para tratamiento de enfermedad pulmonar obstructiva cronica.